2020 annual financial data
Neumora Therapeutics 2020 Operating cash flow
Direct answer
Operating cash flow was -26,760,000 USD.
Operating income was -95,518,000 USD and net income was -99,272,000 USD.
Operating cash flow was -26,760,000 USD.
Get free Neumora Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -95,518,000 USD
- Net income
- -99,272,000 USD
- Operating cash flow
- -26,760,000 USD